Descripción El curso de biotecnología del medio ambiente abarca los marcos teóricos y prácticos respecto a los principios, tecnologías y aplicaciones de los procesos biológicos como alternativa de solución a los problemas ambientales que enfrenta el país, tales como la contaminación del suelo y el agua, así como la generación excesiva de residuos sólidos y líquidos, con énfasis en los procesos biológicos, sistemas microbianos y vegetales, así como el conocimiento de su aplicación mediante ejemplos en el contexto científico actual y la experimentación en laboratorio Dentro de las técnicas biotecnológicas que abordará el curso se encuentran la biorremediación (bacteriana y vegetal), tratamiento de residuos sólidos y su puesta en valor (compost, biogas), tratamiento biológico de aguas residuales, entre otros. Propósito El curso de Biotecnología del Medio Ambiente ...

HIGH-FLOW NON-INVASIVE VENTILATION (NIV) DEVICES REDUCE THE MORBIDITY AND MORTALITY OF COVID-19. THE OBJECTIVE WAS TO EVALUATE THE USE OF THE NON-INVASIVE VENTILATION DEVICE WITH HIGH-FLOW HELMET CPAP DESIGNED IN PERU IN PATIENTS WITH SEVERE ACUTE RESPIRATORY SYNDROME (COVID-19) HOSPITALIZED IN THE EMERGENCY SERVICES OF FIVE HOSPITALS. PROSPECTIVE MULTICENTER AND CROSS-SECTIONAL OBSERVATIONAL STUDY FROM FIVE HOSPITALS FROM JULY TO AUGUST 2020. 19 PATIENTS WERE RECRUITED AND DIVIDED INTO TWO GROUPS (G-1 N = 10; G-2 N = 9) APPLYING CLINICAL AND GASOMETRIC PARAMETERS AS INDICATORS OF DISEASE EVOLUTION UPON HOSPITAL ADMISSION AND WITHIN 24 HOURS. A PROGRESSIVE INCREASE IN THESE PARAMETERS WAS OBSERVED IN THOSE PATIENTS WHO USED THE NIV CPAP HELMET WITHIN THE FIRST 24 HOURS. IN G-01, IMPROVEMENT WAS EVIDENT IN 90% (N = 9/10): PAO2 (RANGE 48–137; AVERAGE: 82.49 ± 8.07; P-VALUE = 0.008), CO2...

High-flow non-invasive ventilation (NIV) devices reduce the morbidity and mortality of COVID-19. The objective was to evaluate the use of the non-invasive ventilation device with high-flow helmet CPAP designed in Peru in patients with severe acute respiratory syndrome (COVID-19) hospitalized in the emergency services of five hospitals. Prospective multicenter and cross-sectional observational study from five hospitals from July to August 2020. 19 patients were recruited and divided into two groups (G-1 n = 10; G-2 n = 9) applying clinical and gasometric parameters as indicators of disease evolution upon hospital admission and within 24 hours. A progressive increase in these parameters was observed in those patients who used the NIV CPAP helmet within the first 24 hours. In G-01, improvement was evident in 90% (n = 9/10): PaO2 (range 48–137; average: 82.49 ± 8.07; p-value = 0.008), CO2...

The CYP1A1 isoenzyme is responsible for the biotransformation of procarcinogens, such as Benzo(a)pyrene, into reactive metabolites. Meanwhile, GSTM1 facilitates the detoxification of these metabolites by conjugating them with glutathione. The presence of the CYP1A1*2A genetic variant intensifies the production of these reactive metabolites, and the deletion of the GSTM1 gene (GSTM1*0) impairs their detoxification. This enzymatic imbalance leads to the formation of DNA adducts, which are known to contribute to cancer and other diseases. Given the importance of studying these genes within the framework of 4P medicine (predictive, preventive, personalized, and participatory), the primary objective of this study was to investigate the prevalence of GSTM1*0 and CYP1A1*2A in the central Peruvian coastal Population as genetic biomarkers. The study included 131 individual residents of the Peruvi...

The CYP1A1 isoenzyme is responsible for the biotransformation of procarcinogens, such as Benzo(a)pyrene, into reactive metabolites. Meanwhile, GSTM1 facilitates the detoxification of these metabolites by conjugating them with glutathione. The presence of the CYP1A1*2A genetic variant intensifies the production of these reactive metabolites, and the deletion of the GSTM1 gene (GSTM1*0) impairs their detoxification. This enzymatic imbalance leads to the formation of DNA adducts, which are known to contribute to cancer and other diseases. Given the importance of studying these genes within the framework of 4P medicine (predictive, preventive, personalized, and participatory), the primary objective of this study was to investigate the prevalence of GSTM1*0 and CYP1A1*2A in the central Peruvian coastal Population as genetic biomarkers. The study included 131 individual residents of the Peruvi...

The major production of artisanal and industrial wines is elaborate in the Ica Valley, Peru. The objective was to evaluate the antioxidant activity of polyphenols and permissible values of glyphosate in artisanal wines from the Pisco Routes of the Ica Valley, Peru. Samples: six coded artisanal wines and two commercial brands as references (60088 and 60089). Total polyphenol content (TPC) was found between 107.90 ± 0.30 (60091) and 234.73 ± 0.61 mg GAE/100 mL (60084); total flavonoid content (TFC) was between 9.70 ± 0.30 (60091) and 16.83 ± 0.25 mg QE/100 mL (60084). Antioxidant activity: DPPH between 34.9 ± 0.44 (60091) and 55.6 ± 0.30 mM TEAC/100 mL (60085). FRAP between 42.50 ± 0.36 (60091) and 117.3 ± 0.44 (60085). Correlation relationship: TPC/DPPH (mM TEAC/100 mL) for 60086 (r = 0.7302, R2 = 0.5332), 60091 (r = 0.8029, R2 = 0.6447), 60085 (r = -0.9820, R2 = 0.9643), and for ...

The major production of artisanal and industrial wines is elaborate in the Ica Valley, Peru. The objective was to evaluate the antioxidant activity of polyphenols and permissible values of glyphosate in artisanal wines from the Pisco Routes of the Ica Valley, Peru. Samples: six coded artisanal wines and two commercial brands as references (60088 and 60089). Total polyphenol content (TPC) was found between 107.90 ± 0.30 (60091) and 234.73 ± 0.61 mg GAE/100 mL (60084); total flavonoid content (TFC) was between 9.70 ± 0.30 (60091) and 16.83 ± 0.25 mg QE/100 mL (60084). Antioxidant activity: DPPH between 34.9 ± 0.44 (60091) and 55.6 ± 0.30 mM TEAC/100 mL (60085). FRAP between 42.50 ± 0.36 (60091) and 117.3 ± 0.44 (60085). Correlation relationship: TPC/DPPH (mM TEAC/100 mL) for 60086 (r = 0.7302, R2 = 0.5332), 60091 (r = 0.8029, R2 = 0.6447), 60085 (r = -0.9820, R2 = 0.9643), and for ...

Background/Objectives: Epilepsy is characterized by recurrent, unprovoked, self-limiting seizures of genetic, acquired, or unknown origin. It affects more than 50 million people worldwide. The prevalence in Peru is 11.9–32.1 per 1000 people. Our objective was to describe the association between CYP2C9 and CYP2C19 genetic polymorphisms and adverse reactions induced by antiseizure medications among Peruvian patients with epilepsy. Methods: A descriptive observational study was conducted on Peruvian patients with epilepsy. Non-probability, non-randomized, purposive sampling was carried out through consecutive inclusion. Genomic DNA was obtained from venous blood samples. Genotypes were determined by real-time PCR using specific TaqMan probes to identify the alleles of interest. Results: In total, 89 Peruvian patients with epilepsy were recruited at the Alberto Sabogal Sologuren National H...